Clinical Trials Browser

INDUSTRY × Carcinoma, Hepatocellular × vandetanib × Clear all

NCT00508001 2016-10-10

Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)

Phase 2 Completed

67 enrolled 12 charts

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms